Sinofn Health
Sinofn Health
The Foods for Special Medical Purposes (FSMP) sector in Greece is undergoing a transformation. As the demographic landscape shifts toward an aging population, the prevalence of metabolic disorders, sarcopenia, and oncology-related nutritional deficiencies has necessitated a paradigm shift in healthcare procurement. Greek hospitals and retail pharmacy networks are increasingly seeking science-driven OEM partners capable of bridging the gap between clinical efficacy and cost-effective accessibility.
Greece’s health sector, influenced by EU directives and regional Mediterranean dietary habits, is moving toward preventative and therapeutic nutritional intervention. We observe three key trends:
Backed by the Chinese Academy of Sciences, SINOFN represents the convergence of high-tech R&D and manufacturing scale. Our approach is not merely transactional; we operate as an extension of your product development team. Whether you are a Greek pharmaceutical distributor or a health-tech startup, our "Science-Driven OEM" model offers:
At SINOFN, our medical innovation department, directed by PhD-level experts from Peking University, focuses on metabolic disorder formulations. We treat the Greek market’s requirements with precision, providing clinical-grade documentation essential for hospital tenders and pharmacy sales.
Our facility is not just a factory; it is a validated clinical nutrition ecosystem. With ISO 9001, ISO 22000, and HACCP certifications, we ensure that your product journey—from raw material storage to final packaging—is auditable and secure. We specialize in complex formulations that many standard manufacturers cannot handle, such as advanced MCTS, peptide powders, and PQQ precursors.
A: We provide a comprehensive documentation package, including COAs, Stability Reports, and raw material traceability, specifically curated to meet the scrutiny of EU customs and health regulatory bodies. Our team is well-versed in the specific compliance standards for Greece.
A: Yes. We understand that entering a new market like Greece requires risk mitigation. We offer pilot-scale prototyping and MOQ flexibility for qualified strategic partners to validate product-market fit.
A: We offer end-to-end support, from raw material sourcing and formulation R&D to packaging design and logistics. We view ourselves as your manufacturing partner, not just a supplier.
